États-Unis · Plateformes & données · The Motley Fool

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.

Publié par The Motley Fool · États-Unis il y a 1 h

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story. — Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story. · The Motley Fool

Résumé détaillé

Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

Washington can start delivering on affordability by rejecting Trump’s tariffs

Adobe's new agentic tools appear impressive, but BTIG seeks more evidence of growth

Brookfield, CPPIB consortium enters next round in Uniper sales process, sources say

Eric Trump-backed robot soldier startup can't pay staff after founder borrowed $4.6 million from company to buy home

Bernicke Wealth Management Ltd. Makes New Investment in Intel Corporation $INTC

Apple users are about to lose something they’ve had for 28 years